These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9684890)

  • 1. Cloning, expression, and purification of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase: crystallization of nucleic acid complexes.
    Sun D; Jessen S; Liu C; Liu X; Najmudin S; Georgiadis MM
    Protein Sci; 1998 Jul; 7(7):1575-82. PubMed ID: 9684890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
    Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
    J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and energetic characterization of nucleic acid-binding to the fingers domain of Moloney murine leukemia virus reverse transcriptase.
    Crowther RL; Remeta DP; Minetti CA; Das D; Montano SP; Georgiadis MM
    Proteins; 2004 Oct; 57(1):15-26. PubMed ID: 15326591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A directed approach to improving the solubility of Moloney murine leukemia virus reverse transcriptase.
    Das D; Georgiadis MM
    Protein Sci; 2001 Oct; 10(10):1936-41. PubMed ID: 11567084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase.
    Georgiadis MM; Jessen SM; Ogata CM; Telesnitsky A; Goff SP; Hendrickson WA
    Structure; 1995 Sep; 3(9):879-92. PubMed ID: 8535782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid substitutions away from the RNase H catalytic site increase the thermal stability of Moloney murine leukemia virus reverse transcriptase through RNase H inactivation.
    Konishi A; Hisayoshi T; Yokokawa K; Barrioluengo V; Menéndez-Arias L; Yasukawa K
    Biochem Biophys Res Commun; 2014 Nov; 454(2):269-74. PubMed ID: 25450388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
    Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM
    J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an N-terminal fragment from moloney murine leukemia virus reverse transcriptase to facilitate crystallization and analysis of a pseudo-16-mer DNA molecule containing G-A mispairs.
    Coté ML; Yohannan SJ; Georgiadis MM
    Acta Crystallogr D Biol Crystallogr; 2000 Sep; 56(Pt 9):1120-31. PubMed ID: 10957631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
    Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K
    Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a pseudo-16-mer DNA with stacked guanines and two G-A mispairs complexed with the N-terminal fragment of Moloney murine leukemia virus reverse transcriptase.
    Coté ML; Georgiadis MM
    Acta Crystallogr D Biol Crystallogr; 2001 Sep; 57(Pt 9):1238-50. PubMed ID: 11526315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed mutagenesis of Moloney murine leukemia virus reverse transcriptase. Demonstration of lysine 103 in the nucleotide binding site.
    Basu A; Basu S; Modak MJ
    J Biol Chem; 1990 Oct; 265(28):17162-6. PubMed ID: 1698772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus.
    Das D; Georgiadis MM
    Structure; 2004 May; 12(5):819-29. PubMed ID: 15130474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystals of a ternary complex of human immunodeficiency virus type 1 reverse transcriptase with a monoclonal antibody Fab fragment and double-stranded DNA diffract x-rays to 3.5-A resolution.
    Jacobo-Molina A; Clark AD; Williams RL; Nanni RG; Clark P; Ferris AL; Hughes SH; Arnold E
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10895-9. PubMed ID: 1720554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity.
    Kotewicz ML; Sampson CM; D'Alessio JM; Gerard GF
    Nucleic Acids Res; 1988 Jan; 16(1):265-77. PubMed ID: 2448747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel and simple method for high-level production of reverse transcriptase from Moloney murine leukemia virus (MMLV-RT) in Escherichia coli.
    Chen Y; Xu W; Sun Q
    Biotechnol Lett; 2009 Jul; 31(7):1051-7. PubMed ID: 19330487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template.
    Telesnitsky A; Goff SP
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1276-80. PubMed ID: 7679498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
    Goedken ER; Marqusee S
    Proteins; 1998 Oct; 33(1):135-43. PubMed ID: 9741851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: identification of the N-terminal cleavage site by mass spectrometry.
    Agbuya PG; Sherman NE; Moen LK
    Arch Biochem Biophys; 2001 Aug; 392(1):93-102. PubMed ID: 11469799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity labeling of the primer binding domain in murine leukemia virus reverse transcriptase.
    Tirumalai RS; Modak MJ
    Biochemistry; 1991 Jul; 30(26):6436-43. PubMed ID: 1711370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.